Loading...
Please wait while we get things ready for you
Please wait while we get things ready for you
The WHO pledged to eliminate viral hepatitis by 2030, but 287 million people remain infected, 1.3 million die annually, and funding is falling. Here's why the...
A blistering new investigation reveals that medical device regulators are approving products with deadly flaws — from defibrillators that spark and burn to home...
From humidifiers causing third-degree burns to STI tests missing infections, a string of recent medical device failures reveals a regulatory system that's...
New research reveals that having both excess body fat and poor muscle health dramatically increases type 2 diabetes risk, far more than either condition alone.
A record-breaking Cyclospora outbreak has infected thousands, with leafy greens and funding cuts under scrutiny. We break down the debate and what it means for...
Anthropic launched Claude Science and announced it will develop its own drugs. NVIDIA integrated BioNeMo into the platform. A patent for AI-native biology was...
Medicare just slashed GLP-1 prices to $50 a month for 14 million seniors — but new research on taste loss, eating disorder misuse, and record $5.7 trillion...
From UPS investing $48M in cold chain logistics to bridal shops requiring waivers, from boosting male fertility to reshaping what Britons buy at the grocery...
A new study links GLP-1 drugs like Ozempic to reduced violent behavior, sparking debate about whether these weight loss medications could be the next frontier...
GLP-1 drugs are rewriting the rules of weight loss, but a growing body of evidence suggests they may come with a hidden cost: muscle loss and a dangerous slide...
A government study on alcohol risks was sidelined amid industry pressure. The findings show health costs start at just one drink a day.
Universal, AI-driven vaccine platforms sound like science fiction—until you remember measles and whooping cough don’t care about trends. Here’s what recent AI...